Books on the topic 'High density lipoproteins'

von Eckardstein, Arnold, and Dimitris Kardassis, eds. High Density Lipoproteins. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-09665-0.

Kontush, Anatol, and M. John Chapman. High-Density Lipoproteins. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2011. http://dx.doi.org/10.1002/9781118158678.

International Symposium on Plasma High Density Lipoproteins and Atherosclerosis (3rd 1992 San Antonio, Tex.). High density lipoproteins and atherosclerosis III: Proceedings of the 3rd International Symposium on Plasma High Density Lipoproteins and Atherosclerosis, San Antonio, 4-6 March 1992. Edited by Miller N. E. 1943- and Tall Alan R. Amsterdam: Excerpta Medica, 1992.

High density lipoproteins, dyslipidemia, and coronary heart disease. New York: Springer, 2010.

Kontush, Anatol, and M. John Chapman. High-density lipoproteins: Structure, metabolism, function, and therapeutics. Hoboken, N.J: John Wiley & Sons, Inc., 2012.

Cho, Kyung-Hyun. High-Density Lipoproteins as Biomarkers and Therapeutic Tools. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-7383-1.

Cho, Kyung-Hyun. High-Density Lipoproteins as Biomarkers and Therapeutic Tools. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-7387-9.

Schaefer, Ernst J., ed. High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1059-2.

High-density lipoproteins: Structure, metabolism, function, and therapeutics. Hoboken, N.J: John Wiley & Sons, Inc., 2012.

Lupovici, Zaharia. Good cholesterol, bad cholesterol, and the most discussed cholesterol-- HDL. New York: Vantage Press, 1992.

Eckardstein, Arnold von. High Density Lipoproteins: From Biological Understanding to Clinical Exploitation. Cham: Springer Nature, 2015.

1943-, Miller N. E., ed. High density lipoproteins and atherosclerosis II: Proceedings of the Second International Symposium on High Density Lipoproteins and Atherosclerosis, held in Leeds Castle, Maidstone, England on October 6-8, 1988. Amsterdam: Excerpta Medica, 1989.

Walker, Janice. Analysis of the long term effect of physical activity level on high-density and low-density lipoproteins. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1992.

Miller, Naomi. Triglyceride, high density lipoprotein, and coronary heart disease: January 1989 through February 1992 plus selected earlier literature : 1636 citations. Bethesda, Md: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section ; Washington, D.C. : Sold by the Supt. of Docs., U.S. G.P.O., 1992.

Turun yliopisto. Cardiorespiratory Research Unit. and Turun yliopisto. Dept. of Medicine., eds. Factors influencing tracking of serum lipid values in children and young adults: A 9-year follow-up study. Turku: Turun Yliopisto, 1991.

S, Pagano Irwin, and Strait Nathan B, eds. HDL and LDL cholesterol physiology and clinical significance. Hauppauge, NY: Nova Science Publishers, 2009.

service), ScienceDirect (Online, ed. The HDL handbook: Biological functions and clinical implications. London: Academic, 2010.

Lockton, John Andrew. A study of the quantitative and qualitative changes in triglyceride-rich lipoproteins inthe postprandial period and related change in high density lipoprotein cholesterol, preheparin plasma lipase activity, insulin and glucose in insulin dependent diabetis mellitus and controls. Manchester: University of Manchester, 1993.

Kerry-Anne, Rye, ed. High density lipoprotein cholesterol: The new target ; a handbook for clinicians. 3rd ed. Edgbaston: Sherborne Gibbs, 2007.

Kontush, Anatol, and M. John Chapman. High-Density Lipoproteins. Wiley & Sons, Incorporated, John, 2012.

Fielding, Christopher J., ed. High‐Density Lipoproteins. Wiley, 2007. http://dx.doi.org/10.1002/9783527625178.

Fielding, Christopher J. High-Density Lipoproteins: From Basic Biology to Clinical Aspects. Wiley & Sons, Limited, John, 2008.

Fielding, Christopher J. High-Density Lipoproteins: From Basic Biology to Clinical Aspects. Wiley & Sons, Incorporated, John, 2008.

High-Density Lipoproteins: From Basic Biology to Clinical Aspects. Wiley-VCH, 2007.

Miller, N. E., and Alan R. Tall. High Density Lipoproteins and Atherosclerosis III: Proceedings (International Congress Series). Excerpta Medica, 1992.

J, Fielding Christopher, ed. High-density lipoproteins: From basic biology to clinical aspects. Weinheim: Wiley-VCH, 2007.

Miller, Norman E. High Density Lipoproteins and Atherosclerosis (International Congress). Elsevier, 1989.

L, Catapano Alberico, Bernini Franco, and Corsini Alberto, eds. High density lipoproteins: Physiopathology and clinical relevance. New York: Raven Press, 1993.

Schaefer, Ernst J. High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease. Springer, 2016.

Schaefer, Ernst J. High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease. Springer, 2011.

Kontush, Anatol, and M. John Chapman. High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics. Wiley & Sons, Incorporated, John, 2011.

Kontush, Anatol, and M. John Chapman. High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics. Wiley & Sons, Incorporated, John, 2011.

L, Catapano Alberico, Salvioli G, and Vergani Carlo, eds. High-density lipoproteins: Physiopathological aspects and clinical significance. New York: Raven Press, 1987.

Kontush, Anatol, and M. John Chapman. High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics. Wiley & Sons, Incorporated, John, 2011.

Catapano, Alberico L., and Franco Bernini. High Density Lipoproteins: Physiopathology and Clinical Relevance (Atherosclerosis Reviews). Raven Pr, 1993.

Eckardstein, Arnold von, and Dimitris Kardassis. High Density Lipoproteins: From Biological Understanding to Clinical Exploitation. Springer, 2015.

Eckardstein, Arnold von, and Dimitris Kardassis. High Density Lipoproteins: From Biological Understanding to Clinical Exploitation. Springer, 2016.

Catapano, Alberico L., and Gianfranco Salvioli. High-Density Lipoproteins: Physiopathological Aspects and Clinical Significance (Atherosclerosis Reviews). Raven Pr, 1987.

Carlson, L. A. Disorders of HDL. Smith-Gordon & Co Ltd, 1990.

A, Carlson Lars, and Karolinska sjukhuset, eds. Disorders of HDL: Proceedings of the International Symposium, held at the Karolinska Hospital, Stockholm, 7-8 June 1990. London: Smith-Gordon, 1990.

Influence of ganglioslide [sic] GM3 and high density lipoprotein (HDL) on tumor cell cohesion. 1996.

Twisk, Jos, and Isabel Ferreira. Physical activity, physical fitness, and cardiovascular health. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199232482.003.0025.

Komoda, Tsugikazu. HDL Handbook: Biological Functions and Clinical Implications. Elsevier Science & Technology Books, 2017.

Komoda, Tsugikazu. HDL Handbook: Biological Functions and Clinical Implications. Elsevier Science & Technology Books, 2013.

Komoda, Tsugikazu. HDL Handbook: Biological Functions and Clinical Implications. Elsevier Science & Technology Books, 2013.

G, Assmann, ed. HDL deficiency and atherosclerosis. Dordrecht: Kluwer Academic Publishers, 1995.

Mertens, Ann. Relation Between Qualitative Changes in High- And Low-Density Lipoproteins & Their (Anti) Atherogenic Potential in Obesity. Leuven Univ Pr, 2002.

Comparison of total and high-density lipoprotein cholesterol in male recreational swimmers and sedentary controls. 1986.

Comparison of total and high-density lipoprotein cholesterol in male recreational swimmers and sedentary controls. 1985.

The effects of chronic exercise on prostacyclin (PGI2, epoprostenol), high density lipoproteins (HDL), and total cholesterol (TC). 1985.